Welcome into the CardioVascular clinical trials community
How should we interpret the results of the major recent trials?
What is the impact on clinical practice?
How can we design and conduct better and cheaper trials that address true unmet needs?
How can we improve operating procedures and streamline trial execution?
How to operate within the regulatory environment? Foster cross-talk with regulatory agencies?
And more generally, how to create better and safer methods for treating cardiovascular disease?
The Global CardioVascular Clinical Trialists Forum (CVCT) is dedicated to the discussion of clinical trials in cardiovascular disease and aims to provide answers to these questions.
CVCT is a true Forum where scientific productivity and peer-to-peer exchange are at their best.
CVCT meetings are unique, bringing together a carefully selected faculty of opinion leaders, clinical trialists, investigators, regulators, statisticians, industry R&D experts, decision makers and practitioners.
Over the years CVCT has attracted audience from over 30 different countries, with participants coming from Western and Eastern Europe, the USA, South America, Asia and Middle East.
The meeting encourages knowledge-sharing between participants as CVCT aims to familiarize practitioners and investigators with the science of clinical trials from protocol design to result interpretation.
Further, CVCT Forum puts attendees into direct contact with primary investigators, senior trial scientists as well as research and development experts from pharmaceutical/device companies and experts from regulatory agencies.
We hope you will agree that CVCT is an ideal meeting place for anyone eager to communicate with physicians and the people who are committed to creating and analyzing major trials and to raising awareness and bringing about change within the sector.
We look forward to meeting and sharing ideas with you.